Wells Fargo’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
21,160
+8,687
| +70% | +$728K | ﹤0.01% | 2989 |
|
|
2025
Q1 | $891K | Sell |
12,473
-74
| -0.6% | -$5.29K | ﹤0.01% | 3324 |
|
|
2024
Q4 | $564K | Buy |
12,547
+3,610
| +40% | +$162K | ﹤0.01% | 3636 |
|
|
2024
Q3 | $451K | Buy |
8,937
+1,291
| +17% | +$65.2K | ﹤0.01% | 3695 |
|
|
2024
Q2 | $312K | Buy |
7,646
+7,082
| +1,256% | +$289K | ﹤0.01% | 3868 |
|
|
2024
Q1 | $24.1K | Buy |
564
+449
| +390% | +$19.2K | ﹤0.01% | 5143 |
|
|
2023
Q4 | $4.63K | Buy |
115
+82
| +248% | +$3.3K | ﹤0.01% | 5525 |
|
|
2023
Q3 | $974 | Sell |
33
-7
| -18% | -$207 | ﹤0.01% | 5835 |
|
|
2023
Q2 | $172 | Buy |
40
+2
| +5% | +$9 | ﹤0.01% | 6434 |
|
|
2023
Q1 | $81 | Hold |
38
| – | – | ﹤0.01% | 6661 |
|
|
2022
Q4 | $75 | Buy |
38
+1
| +3% | +$2 | ﹤0.01% | 6542 |
|
|
2022
Q3 | $0 | Sell |
37
-6
| -14% | – | ﹤0.01% | 6948 |
|
|
2022
Q2 | $0 | Buy |
43
+20
| +87% | – | ﹤0.01% | 7089 |
|
|
2022
Q1 | $0 | Hold |
23
| – | – | ﹤0.01% | 7175 |
|
|
2021
Q4 | $0 | Hold |
23
| – | – | ﹤0.01% | 7160 |
|
|
2021
Q3 | $0 | Sell |
23
-1
| -4% | – | ﹤0.01% | 7076 |
|
|
2021
Q2 | $0 | Sell |
24
-1,230
| -98% | – | ﹤0.01% | 6968 |
|
|
2021
Q1 | $24K | Sell |
1,254
-4,408
| -78% | -$84.4K | ﹤0.01% | 5740 |
|
|
2020
Q4 | $163K | Sell |
5,662
-1,331
| -19% | -$38.3K | ﹤0.01% | 5023 |
|
|
2020
Q3 | $263K | Buy |
6,993
+3,241
| +86% | +$122K | ﹤0.01% | 4654 |
|
|
2020
Q2 | $125K | Buy |
3,752
+3,743
| +41,589% | +$125K | ﹤0.01% | 4928 |
|
|
2020
Q1 | $0 | Buy |
+9
| New | – | ﹤0.01% | 6302 |
|